Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086463 · ClinicalTrials.gov registry record · Phase 2
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2 study, sponsored by Actelion.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00086463 is a Phase 2 study that has completed, run by Actelion. The registered enrollment target is 60 participants.
The verdict
NCT00086463, a Phase 2 study, has completed, sponsored by Actelion.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of Iloprost in subjects that have Pulmonary Arterial Hypertension who are concurrently taking bosentan (Tracleer TM).
Interventions
- DRUG Iloprost or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00086463
The ClinicalTrials.gov registry entry for NCT00086463 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actelion, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Iloprost or placebo is the first listed.
NCT00086463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00086463 about?
NCT00086463 is a clinical study titled "Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)". The purpose of this study is to determine the safety and efficacy of Iloprost in subjects that have Pulmonary Arterial Hypertension who are concurrently taking bosentan (Tracleer TM).
What is the current status of trial NCT00086463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2004-06. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00086463?
The interventions under investigation include: Iloprost or placebo (DRUG).
Who is sponsoring clinical trial NCT00086463?
This trial is sponsored by Actelion, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.